⚖

Compare Funds

See how two funds stack up side by side, real returns, risk, cost and portfolio overlap.

MF
—Mirae Asset Midcap Fund - Growth - Direct PlanDirect · Growth
₹40.22 as on 30 Oct 2026
VS
HD
HDFC MFHDFC Pharma and Healthcare Fund - Growth - Direct PlanDirect · Growth
₹21.95 as on 30 Oct 2026
▤Key Metrics Comparison
MetricMFMirae Asset Midcap Fund - Growth - Direct PlanHDHDFC Pharma and Healthcare Fund - Growth - Direct Plan
Snapshot
AMC—HDFC MF
CategoryEquity - Mid Cap FundEquity - Sectoral Fund - Pharma & Health Care
NAV₹40.22 (30 Oct 2026)₹21.95 (30 Oct 2026)
Rating★★★★★★★★
BenchmarkNifty Midcap 150 - TRIBSE Health Care - TRI
Fund ManagerAnkit JainNikhil Mathur
Inception29 Jul 201904 Oct 2023
Returns
1Y-2.16%22.64%
3Y14.58%30.41%
5Y13.38%—
Since Inception21.24%29.15%
Risk
16.4814.07
0.980.59
0.551.59
0.8521.67
1.003.48
-11.20%-9.23%
Costs
Expense Ratio0.97%1.03%
Exit Load1% on or before 365D, Nil after 365D1% on or before 30D, Nil after 30D
Min SIP₹99₹100
Min Lumpsum₹5,000₹100
Lock-inNoneNone

Min SIP is reported per fund, not per plan, every plan of a fund shares the same figure.

◐Portfolio Overlap
Mirae Asset M…97%
HDFC MF97%
3.3%

Only 3.3% of holdings by weight are common between Mirae Asset Midcap Fund - Growth - Direct Plan and HDFC MF, based on each fund's top 20 disclosed holdings, not the full portfolio.

Common holdingMirae Asset Midcap Fund - Growth - Direct PlanHDFC MF
Lupin Ltd.3.34%3.55%

Category context: Equity vs Equity. Open the full Screener →